insights_auto
Why is INO down 2.41%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.62
arrow_downward
-2.41%(-0.040) 1D
$1.59
arrow_downward
-1.85% (-0.030)bedtimeAfter hours
Closed: Nov 4, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.67
High
$1.85
Low
$1.55
Mkt. cap
167.50M
Avg. vol.
15.11M
Volume
21.30M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
Open
$1.67
High
$1.85
Low
$1.55
Mkt. cap
167.50M
Avg. vol.
15.11M
Volume
21.30M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
Kalkine
·
10 hours ago
What Comes Next for Inovio (NASDAQ:INO) After a 224% Jump on Accelerated Approval?
News Corp
·
1 day ago
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
News Corp
·
2 days ago
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc